Banner - NPPA Connect
Opinion|Videos|September 11, 2026

Why Patient-Reported Outcomes Matter in Psoriasis Care

In the concluding episode, Dr. Tina Bhutani-Jacques emphasizes the importance of looking beyond clinical measures such as body surface area when evaluating treatment success in patients with plaque psoriasis.

In the concluding episode, Dr. Tina Bhutani-Jacques emphasizes the importance of looking beyond clinical measures such as body surface area when evaluating treatment success in patients with plaque psoriasis. She explains that routine follow-up visits should include discussions about patient-reported outcomes, including persistent symptoms such as pruritus and pain, as well as the broader impact of psoriasis on quality of life. Dr. Bhutani-Jacques encourages clinicians to ask whether patients have regained the confidence to participate in everyday activities, such as wearing desired clothing, engaging in social events, and feeling comfortable in professional settings. These conversations provide valuable insight into whether treatment truly meets patients' goals and may identify opportunities to optimize therapy.

Dr. Bhutani-Jacques also highlights that persistent symptoms or ongoing quality-of-life impairment should prompt clinicians to reassess the current treatment plan rather than accepting partial disease control. She notes that with the expanding range of available therapies, including newer nonsteroidal topical agents and advanced systemic treatments, it is increasingly realistic to help many patients achieve clear or nearly clear skin while improving overall well-being.

The episode concludes with a forward-looking discussion of how the standard of care for plaque psoriasis has evolved. Dr. Bhutani-Jacques encourages patients who may have become discouraged by previous treatment experiences to reconnect with their dermatologist, as therapeutic options have expanded considerably in recent years. She also encourages primary care clinicians to consider referring patients for re-evaluation, noting that the availability of newer nonsteroidal topical therapies and additional systemic treatment options has transformed psoriasis management. Ultimately, Dr. Bhutani-Jacques reinforces the importance of shared decision-making, ongoing communication, and individualized care to optimize long-term outcomes for patients with plaque psoriasis.

Thank you for watching this Dermatology Times Cased-Based Peer Perspectives series on plaque psoriasis. Please subscribe to our eNewsletter for information on upcoming video series.